Back
ResMed Stock Predictions
Sponsored
RMD
Sponsored
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Sell
49
RMD
ResMed
Last Price:
245.66
Seasonality Move:
12.46%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!ResMed Stock Forecast
- Over the next 52 weeks, ResMed has on average historically risen by 26.3% based on the past 29 years of stock performance.
- ResMed has risen higher in 23 of those 29 years over the subsequent 52-week period, corresponding to a historical accuracy of 79.31%
-
Is ResMed Stock Undervalued?
The current ResMed [RMD] share price is $245.74. The Score for RMD is 49, which is 2% below its historic median score of 50, and infers higher risk than normal. - RMD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will ResMed Stock Go Up Next Year?
- Over the next 52 weeks, ResMed has on average historically risen by 26.3% based on the past 29 years of stock performance.
ResMed Stock Rating
Sell
49
ResMed (RMD)
is a Sell
Is ResMed overpriced?
- ResMed has risen higher in 23 of those 29 years over the subsequent 52-week period, corresponding to a historical accuracy of 79.31%
ResMed Stock Price History
Stock Information
Stock Info
Exchange:
NYSE
Country:
United States
Industry:
Health Care Equipment & Supplies
Sector:
Health Care
Type:
stock
Website:
resmed.com
52-Week Data
52-Week High:
260.49
52-Week Low:
140.81
Prediction Charts
Market Cap:
36.07B
Price in USD:
245.74
Volume:
1.01M
Beta:
0.74
Technical Analysis
SMA50:
242.73
SMA100:
225.17
SMA200:
210.19
52-Wk Change:
60.81%
Stock Predictions
-
Is ResMed stock public?
Yes, ResMed is a publicly traded company. -
What is the ResMed stock quote today?
The ResMed stock price is 245.74 USD today. -
How to buy ResMed stock online?
You can buy ResMed shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-16 | 238.19 | 238.34 | 242.11 | 237.45 |
Oct-18 | 240.60 | 240.00 | 241.67 | 237.78 |
Oct-21 | 241.06 | 240.05 | 242.44 | 238.40 |
Oct-22 | 239.06 | 239.98 | 241.17 | 237.63 |
Oct-23 | 239.13 | 237.40 | 240.22 | 235.08 |
Oct-24 | 237.46 | 239.05 | 243.99 | 237.46 |
Oct-25 | 260.00 | 256.07 | 260.49 | 252.80 |
Oct-28 | 258.00 | 246.83 | 259.33 | 246.27 |
Oct-29 | 247.62 | 244.40 | 250.09 | 243.83 |
Oct-30 | 243.30 | 243.02 | 245.85 | 241.06 |
Oct-31 | 242.00 | 242.47 | 243.67 | 240.53 |
Nov-1 | 242.00 | 244.28 | 246.77 | 241.12 |
Nov-4 | 245.00 | 243.61 | 247.75 | 242.84 |
Nov-5 | 243.61 | 245.74 | 246.51 | 241.28 |
ResMed Earnings
ResMed Earnings Report: Per Share ResMed Earnings Q1 Q2 Q3 and Q4 last year and next year.
ResMed Forecast Revenue Growth
ResMed Stock Analysis: Historical quarterly revenues per share for ResMed and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.18 per share, and an increase next year of $1.69 per share.
* ResMed stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.